The landscape of diabetes care is advancing with the emergence of skin-applied GLP-1 therapy. These innovative devices offer a likely simpler alternative to needle administrations for individuals dealing with diabetes 2. Such a system deliver glucagon-like peptide-1 directly through the skin , avoiding the need for regular injections and perhaps in